(Q34318837)

1 August 2017

1 reference

title

Treatment approaches for Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy (English)

1 reference

chronic inflammatory demyelinating polyradiculoneuropathy

1 August 2017

Guillain–Barré syndrome

0 references

0 references

author name string

Lindenbaum Y

series ordinal

1

1 reference

PubMed ID

11471764

1 August 2017

Kissel JT

series ordinal

2

1 reference

PubMed ID

11471764

1 August 2017

Mendell JR

series ordinal

3

1 reference

1 August 2017

1 February 2001

1 reference

1 August 2017

1 reference

1 August 2017

19

1 reference

1 August 2017

1

1 reference

1 August 2017

187-204

1 reference

Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 8-1990. A 45-year-old woman with Hodgkin's disease and a neurologic disorder

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

The use of intravenous immunoglobulin in Miller Fisher syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

The inflammatory lesion in idiopathic polyneuritis. Its role in pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

Recurrent polyneuropathies and their corticosteroid treatment; with five-year observations of a placebo-controlled case treated with corticotrophin, cortisone, and prednisone

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

Cyclosporin A in resistant chronic inflammatory demyelinating polyradiculoneuropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

Chronic inflammatory demyelinating polyradiculoneuropathy. Clinical characteristics, course, and recommendations for diagnostic criteria

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

Chronic inflammatory demyelinating polyradiculoneuropathy: Comparison of patients with and without an associated monoclonal gammopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

Human immune globulin infusion in Guillain-Barré syndrome: worsening during and after treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

Improvement following interferon beta in chronic inflammatory demyelinating polyradiculoneuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

Hypertrophic brachial plexus neuritis: a pathological study of two cases

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

Nerve root hypertrophy in chronic inflammatory demyelinating polyneuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

Intensive evaluation of referred unclassified neuropathies yields improved diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

An acute axonal form of Guillain-Barré polyneuropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

Severe axonal degeneration in acute Guillain-Barré syndrome: evidence of two different mechanisms?

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

Campylobacter jejuni, antiganglioside antibodies, and Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

An Unusual Variant of Acute Idiopathic Polyneuritis (Syndrome of Ophthalmoplegia, Ataxia and Areflexia)

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

Bisphosphonates: preclinical aspects and use in osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

Appropriate number of plasma exchanges in Guillain-Barré syndrome. The French Cooperative Group on Plasma Exchange in Guillain-Barré Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

Efficiency of plasma exchange in Guillain-Barré syndrome: role of replacement fluids. French Cooperative Group on Plasma Exchange in Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

Plasma exchange in Guillain-Barré syndrome: one-year follow-up. French Cooperative Group on Plasma Exchange in Guillain-Barré Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

Recovery from chronic progressive polyneuropathy after treatment with plasma exchange and cyclophosphamide

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

Natural course of acute and chronic monophasic inflammatory demyelinating polyneuropathies (IDP). A retrospective analysis of 266 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

Prolonged survival of transected nerve fibres in C57BL/Ola mice is an intrinsic characteristic of the axon

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

Calcium-mediated degeneration of the axonal cytoskeleton in the Ola mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

Chronic inflammatory demyelinating polyneuropathy: clinical features and response to treatment in 67 consecutive patients with and without a monoclonal gammopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

Improvement following interferon-alpha 2A in chronic inflammatory demyelinating polyneuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

Pathology of the motor-sensory axonal Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

Guillain-Barré syndrome in northern China. The spectrum of neuropathological changes in clinically defined cases

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

The Guillain-Barré syndrome at 75: TheCampylobacterconnection

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

Acute motor axonal neuropathy: An antibody-mediated attack on axolemma

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

Plasma-exchange therapy in chronic inflammatory demyelinating polyneuropathy. A double-blind, sham-controlled, cross-over study

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy. A double-blind, placebo-controlled, cross-over study.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

Antibodies to gangliosides and galactocerebroside in patients with Guillain-Barré syndrome with preceding Campylobacter jejuni and other identified infections

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

Guillain-Barré syndrome: activated complement components C3a and C5a in CSF

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

Immune reactive C3d on the surface of myelin sheaths in neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

Idiopathic dysautonomia treated with intravenous gammaglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

Cyclosporin A in the treatment of chronic demyelinating polyradiculoneuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

Controlled trial prednisolone in acute polyneuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

Subacute Idiopathic Demyelinating Polyradiculoneuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

Guillain-Barré Syndrome and the 1978–1979 Influenza Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

Relapse in Guillain-Barré syndrome after treatment with human immune globulin

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

Guillain-Barré and Fisher's syndromes subsequent to Campylobacter jejuni enteritis are associated with HLA-B54 and Cw1 independent of anti-ganglioside antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy: pathogenesis and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

Activation of terminal components of complement in patients with Guillain-Barré syndrome and other demyelinating neuropathies

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

Two patterns of clinical recovery in Guillain-Barré syndrome with IgG anti-GM1 antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

Fatal Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

Treatment of chronic relapsing Guillain-Barré syndrome by plasma exchange

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

Acute motor axonal neuropathy with high titer IgG and IgA anti-GD1 a antibodies following Campylobacter enteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

The occurrence of IgM and complement factors along myelin sheaths of peripheral nerves. An immunohistochemical study of the Guillain-Barré syndrome. Preliminary communication

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

HLA and T-cell receptor gene polymorphisms in Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

Chronic dysimmune demyelinating polyneuropathy: a clinical and electrophysiological study of 93 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

Chronic inflammatory demyelinating polyradiculoneuropathy. A clinical and electrophysiological study of 92 cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

Clinical and electrophysiological aspects of acute paralytic disease of children and young adults in northern China

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

Plasma exchange and prednisone in Guillain-Barré syndrome: a controlled randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

Treatment of acute pandysautonomia with intravenous immunoglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

Treatment of Guillain-Barré syndrome: a cost-effectiveness analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

Acute autonomic neuropathy following primary herpes simplex infection

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

Childhood chronic inflammatory demyelinating neuropathies: clinical course and long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

Immunological characterization of surd nerve biopsies from patients with Guillain-Barr� syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

Chronic relapsing polyneuritis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

Campylobacter jejuni and Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

Anti-ganglioside GM1 antibodies in Guillain-Barré syndrome and their relationship to Campylobacter jejuni infection

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

Guillain-Barré syndrome after measles, mumps, and rubella vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

Relapses in the Guillain-Barré syndrome after treatment with intravenous immune globulin or plasma exchange

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

The Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

Treatment of refractory chronic demyelinating polyneuropathy with lymphoid irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

Interferon-alpha may benefit steroid unresponsive chronic inflammatory demyelinating polyneuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

Treatment of Guillain-Barré syndrome with intravenous immunoglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

Effects of nerve constriction on oxygenated excised segments of rat peripheral nerve

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

Treatment of chronic relapsing inflammatory polyradiculoneuropathy by plasma exchange

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

Molecular mimicry in Guillain-Barré syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

Campylobacter jejuni lipopolysaccharides in Guillain-Barré syndrome: molecular mimicry and host susceptibility

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

Encephalo-myelo-radiculo-ganglionitis presenting as pandysautonomia.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

Idiopathic autonomic neuropathy: clinical, neurophysiologic, and follow-up studies on 27 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

Acute renal failure resulting from intravenous immunoglobulin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

Focal upper limb demyelinating neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

Plasma exchange in polyradiculoneuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. Dutch Guillain-Barré Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

Risk factors for treatment related clinical fluctuations in Guillain-Barré syndrome. Dutch Guillain-Barré study group

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

A prospective study of acute idiopathic neuropathy. I. Clinical features and their prognostic value

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

Dysautonomia with acute sensory motor neuropathy. A new classification of acute autonomic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

Pure pan-dysautonomia with recovery. Description and discussion of diagnostic criteria

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

Guillain-Barré syndrome and Fisher's syndrome following Campylobacter jejuni infection

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

High dose immunoglobulin therapy is effective in the Miller Fisher syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

Autonomic involvement in Guillain-Barré syndrome: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970012-8

7 January 2021

10.1016/S0733-8619(05)70012-8

Identifiers

DOI

1 reference

1 August 2017

1 reference

PubMed ID

11471764